What if, rather than focusing solely on the drivers of disease (pathogenesis), we also explored the factors sustaining our ...

Repertoire Immune Medicines Inc. has entered into a collaboration and license agreement with Genentech Inc., a member of the Roche Group, to discover and develop innovative T cell-targeted immune ...

Granite Bio is ready to rock 'n' roll, unveiling with $100 million and hopes of shaping new antibody treatments targeting several autoimmune diseases. The funding consists of a $30 million series ...

Unfortunately, these cells are also active in autoimmune diseases. New research from Japan has found that a certain subpopulation of these white blood cells can predict disease relapse at an early ...

Repertoire will obtain an upfront payment of $35m from Genentech, with the potential for up to $730m in additional milestones ...

Patients with spastic paraplegia type 15 develop movement disorders during adolescence that may ultimately require the use of a wheelchair. In the early stages of this rare hereditary disease the ...

Researchers from The University of Osaka discover that specific white blood cells and the amount of an inflammation protein in the blood can predict relapse of an autoimmune blood vessel disease ...

There are at least 70 documented autoimmune diseases [36] and the prevalence of autoimmune disease is rapidly rising worldwide, for reasons not completely understood. [37] Although the disorders ...

The state’s new interactive tool includes the Centers for Disease Control and Prevention’s tick distribution maps. But it also provides more detailed information, identifying by county where ...

Sanofi says it has reached an agreement with Dren Bio that would see it take control of autoimmune disease treatment DR-0201, a bispecific antibody-based myeloid cell engager with the potential to ...

Health experts warn that ignoring vitamin D deficiency can be detrimental, potentially leading to severe diseases ... it also strengthens the immune system. Get some sun exposure: Most people ...